Wild-type (senile) amyloidosis MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
| pmid = 22974802 | | pmid = 22974802 | ||
}}</ref> | }}</ref> | ||
*ECV expansion is a quantitative marker of the amyloid burden and can detect amyloid fibrils infiltration earlier than conventional testing. | *ECV expansion is a quantitative marker of the amyloid burden and can detect amyloid fibrils infiltration earlier than conventional testing.<ref>{{Cite journal | ||
| author = [[Ana Martinez-Naharro]], [[Thomas A. Treibel]], [[Amna Abdel-Gadir]], [[Heerajnarain Bulluck]], [[Giulia Zumbo]], [[Daniel S. Knight]], [[Tushar Kotecha]], [[Rohin Francis]], [[David F. Hutt]], [[Tamer Rezk]], [[Stefania Rosmini]], [[Candida C. Quarta]], [[Carol J. Whelan]], [[Peter Kellman]], [[Julian D. Gillmore]], [[James C. Moon]], [[Philip N. Hawkins]] & [[Marianna Fontana]] | |||
| title = Magnetic Resonance in Transthyretin Cardiac Amyloidosis | |||
| journal = [[Journal of the American College of Cardiology]] | |||
| volume = 70 | |||
| issue = 4 | |||
| pages = 466–477 | |||
| year = 2017 | |||
| month = July | |||
| doi = 10.1016/j.jacc.2017.05.053 | |||
| pmid = 28728692 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Sanjay M. Banypersad]], [[Marianna Fontana]], [[Viviana Maestrini]], [[Daniel M. Sado]], [[Gabriella Captur]], [[Aviva Petrie]], [[Stefan K. Piechnik]], [[Carol J. Whelan]], [[Anna S. Herrey]], [[Julian D. Gillmore]], [[Helen J. Lachmann]], [[Ashutosh D. Wechalekar]], [[Philip N. Hawkins]] & [[James C. Moon]] | |||
| title = T1 mapping and survival in systemic light-chain amyloidosis | |||
| journal = [[European heart journal]] | |||
| volume = 36 | |||
| issue = 4 | |||
| pages = 244–251 | |||
| year = 2015 | |||
| month = January | |||
| doi = 10.1093/eurheartj/ehu444 | |||
| pmid = 25411195 | |||
}}</ref> | |||
*Increased non-contrast T1 relaxation times are also seen in patients. | |||
==References== | ==References== |
Revision as of 17:58, 19 December 2019
Wild-type (senile) amyloidosis Microchapters |
Differentiating Wild-type (senile) amyloidosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wild-type (senile) amyloidosis MRI On the Web |
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis MRI |
Risk calculators and risk factors for Wild-type (senile) amyloidosis MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
MRI
Cardiovascular Magnetic Resonance (CMR)
- T1 sequence of CMR with the use of gadolinium can differentiate extracellular tissue thickening due to myocardial hypertrophy vs. extracellular deposition.
- Using pre- and post-contrast T1 mapping, extracellular volume (ECV) can be calculated, which is a direct measurement of the cardiac interstitium.[1]
- ECV expansion is a quantitative marker of the amyloid burden and can detect amyloid fibrils infiltration earlier than conventional testing.[2][3]
- Increased non-contrast T1 relaxation times are also seen in patients.
References
- ↑ Francois-Pierre Mongeon, Michael Jerosch-Herold, Otavio Rizzi Coelho-Filho, Ron Blankstein, Rodney H. Falk & Raymond Y. Kwong (2012). "Quantification of extracellular matrix expansion by CMR in infiltrative heart disease". JACC. Cardiovascular imaging. 5 (9): 897–907. doi:10.1016/j.jcmg.2012.04.006. PMID 22974802. Unknown parameter
|month=
ignored (help) - ↑ Ana Martinez-Naharro, Thomas A. Treibel, Amna Abdel-Gadir, Heerajnarain Bulluck, Giulia Zumbo, Daniel S. Knight, Tushar Kotecha, Rohin Francis, David F. Hutt, Tamer Rezk, Stefania Rosmini, Candida C. Quarta, Carol J. Whelan, Peter Kellman, Julian D. Gillmore, James C. Moon, Philip N. Hawkins & Marianna Fontana (2017). "Magnetic Resonance in Transthyretin Cardiac Amyloidosis". Journal of the American College of Cardiology. 70 (4): 466–477. doi:10.1016/j.jacc.2017.05.053. PMID 28728692. Unknown parameter
|month=
ignored (help) - ↑ Sanjay M. Banypersad, Marianna Fontana, Viviana Maestrini, Daniel M. Sado, Gabriella Captur, Aviva Petrie, Stefan K. Piechnik, Carol J. Whelan, Anna S. Herrey, Julian D. Gillmore, Helen J. Lachmann, Ashutosh D. Wechalekar, Philip N. Hawkins & James C. Moon (2015). "T1 mapping and survival in systemic light-chain amyloidosis". European heart journal. 36 (4): 244–251. doi:10.1093/eurheartj/ehu444. PMID 25411195. Unknown parameter
|month=
ignored (help)